JSKN033 Combination Therapy in Subjects With Advanced Cervical Cancer

NCT07497074 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Cervical Cancer

Interventions

DRUG: JSKN033
DRUG: Platinum
DRUG: Bevacizumab

Sponsor

Jiangsu Alphamab Biopharmaceuticals Co., Ltd